Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
Baxter posts strong Q4
03 March 2010
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
Not a subscriber?
Subscribe to Scrip
Request a FREE Trial
RELATED CONTENT
NEWS
Scrip News
Icon rejects Pfizer's Sandwich, but is hungry for 800 of its staff
Focus on Almirall: partnering, new products and mature markets are key targets
GSK focuses on emerging markets as European austerity bites
Reduced quake-related costs boost Chugai's bottom line
Other Informa News
Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
Quarterly results round-up: Alere and Qiagen slash guidance after challenging Q2
COMMENT
Scrip Comment
J&J stent exit – another missed opportunity
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads